Transforming growth factor-beta 1 (TGF-beta) is secreted in a latent form c
onsisting of mature TGF-beta noncovalently associated with its amino-termin
al propeptide, which is called latency associated peptide (LAP). Biological
activity depends upon the release of TGF-beta from the latent complex foll
owing extracellular activation, which appears to be the key regulatory mech
anism controlling TGF-beta action. We have identified two events associated
with latent TGF-beta (LTGF-beta) activation in vivo: increased immunoreact
ivity of certain antibodies that specifically detect TGF-beta concomitant w
ith decreased immunoreactivity of antibodies to LAP. Macrophages stimulated
in vitro with interferon-gamma and lipopolysaccharide reportedly activate
LTGF-beta via cell membrane-bound protease activity. We show through dual i
mmunostaining of paraformaldehyde-fixed macrophages that such physiological
TGF-beta activation is accompanied by a loss of LAP immunoreactivity with
concomitant revelation of TGF-beta epitopes. The induction of TGF-beta immu
noreactivity colocalized with immunoreactive betaglycan/RIII in activated m
acrophages, suggesting that LTGF-beta activation occurs on the cell surface
. Confocal microscopy of metabolically active macrophages incubated with an
tibodies to TGF-beta and betaglycan/RIII prior to fixation supported the lo
calization of activation to the cell surface. The ability to specifically d
etect and localize LTGF-beta activation provides an important tool for stud
ies of its regulation. J. Cell. Physiol. 178:275-283, 1999. (C) 1999 Wiley-
Liss, Inc.